0266-4623

International Journal of Technology Assessment in Health Care

Cambridge University Press

View prefix report (10.1017)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 5215 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact5215 DOIs
2

Deposit reference lists for 3223 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact3223 DOIs
3

Add abstracts to 879 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact879 DOIs

DOIs for this ISSN

Showing the top 5 of 5860 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE… (10.1017/s0266462300103162)
Abstract References ORCID
181.25 260
2 ASSESSMENT OF THE LEARNING CURVE IN HEALTH TECHNOLOGIES (10.1017/s0266462300103149)
Abstract References ORCID
166.90 167
3 A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECT… (10.1017/s0266462300102077)
Abstract References ORCID
149.01 96
4 THE EFFECT OF COCHLEAR IMPLANT USE IN POSTLINGUALLY DEAF ADU… (10.1017/s0266462300102132)
Abstract References ORCID
142.32 78
5 A COMPARISON OF CLINICAL PRACTICE GUIDELINE APPRAISAL INSTRU… (10.1017/s0266462300103095)
Abstract References ORCID
134.43 61
6 CLINICAL JUDGMENT AND CLINICAL PRACTICE GUIDELINES (10.1017/s0266462300103113)
Abstract References ORCID
132.26 57
7 Introduction to the Eur-Assess Report (10.1017/s0266462300010345)
Abstract References ORCID
127.42 49
8 The U.K. NHS ECONOMIC EVALUATION DATABASE (10.1017/s0266462300102016)
Abstract References ORCID
123.26 43
9 SOCIOECONOMIC COSTS OF RHEUMATIC DISEASES (10.1017/s0266462300103228)
Abstract References ORCID
115.81 34
10 WHAT SHOULD BE INCLUDED IN META-ANALYSES? (10.1017/s0266462300103150)
Abstract References ORCID
110.78 29
11 COST-UTILITY ANALYSIS OF INTERFERON BETA-1B IN SECONDARY PRO… (10.1017/s0266462300102041)
Abstract References ORCID
109.68 28
12 IMPROVING CLINICAL PRACTICE GUIDELINES FOR THE 21<scp>ST</sc… (10.1017/s0266462300103034)
Abstract References ORCID
109.68 28
13 THE DEVELOPMENT OF EVIDENCE-BASED CLINICAL PRACTICE GUIDELIN… (10.1017/s0266462300103071)
Abstract References ORCID
109.68 28
14 BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY… (10.1017/s0266462302000284)
References ORCID
109.52 154
15 REPRODUCIBILITY AND RESPONSIVENESS OF EVALUATIVE OUTCOME MEA… (10.1017/s0266462301107038)
References ORCID
109.23 152
16 Reports from the Australian Institute of Health and Welfare… (10.1017/s0266462300005304)
Abstract References ORCID
108.54 27
17 CAN ECONOMIC EVALUATION GUIDELINES IMPROVE EFFICIENCY IN RES… (10.1017/s0266462300103216)
Abstract References ORCID
107.35 26
18 BAYESIAN VALUE-OF-INFORMATION ANALYSIS (10.1017/s0266462301104058)
References ORCID
106.19 132
19 USING PRACTICE GUIDELINES TO ALLOCATE MEDICAL TECHNOLOGIES (10.1017/s026646230010306x)
Abstract References ORCID
106.12 25
20 CHARACTERISTICS OF HIGH-QUALITY GUIDELINES (10.1017/s026646230300014x)
References ORCID
105.70 129
21 THE ACCURACY OF SELF-REPORTED HEALTHCARE RESOURCE UTILIZATIO… (10.1017/s026646230200051x)
References ORCID
104.67 123
22 ASSESSING MEDICAL TECHNOLOGIES IN DEVELOPMENT (10.1017/s0266462300103253)
Abstract References ORCID
103.52 23
23 THE PRACTICE OF DISCOUNTING IN ECONOMIC EVALUATIONS OF HEALT… (10.1017/s0266462300105094)
References ORCID
102.65 112
24 COST-EFFECTIVENESS OF INTERFERON BETA-1B IN SLOWING MULTIPLE… (10.1017/s026646230010203x)
Abstract References ORCID
100.68 21
25 MEASURING COSTS IN COST-UTILITY ANALYSES (10.1017/s0266462300161100)
References ORCID
100.22 100
26 DEVELOPMENT OF EXPLICIT CRITERIA FOR TOTAL KNEE REPLACEMENT (10.1017/s0266462303000060)
References ORCID
99.56 97
27 HEALTH TECHNOLOGY ASSESSMENT IN CANADA (10.1017/s0266462300102168)
Abstract References ORCID
99.17 20
28 CLINICAL PRACTICE GUIDELINES AND THE COST OF CARE (10.1017/s0266462300103137)
Abstract References ORCID
99.17 20
29 FROM CLINICAL RECOMMENDATIONS TO MANDATORY PRACTICE (10.1017/s0266462300103046)
Abstract References ORCID
97.58 19
30 BEYOND MEDLINE (10.1017/s0266462303000163)
References ORCID
96.98 86
31 BIOMEDICAL RESEARCH PRODUCTIVITY (10.1017/s0266462303000229)
References ORCID
96.47 84
32 Measuring Gain in the Evaluation of Medical Technology The P… (10.1017/s0266462300007728)
Abstract ORCID
95.15 79
33 THE VALUATION OF INFORMAL CARE IN ECONOMIC APPRAISAL (10.1017/s0266462399152346)
References ORCID
94.88 78
34 IS THERE A TECHNOLOGICAL IMPERATIVE IN HEALTH CARE? (10.1017/s0266462302000491)
References ORCID
94.32 76
35 IMPACT OF QUALITY ITEMS ON STUDY OUTCOME (10.1017/s0266462300103174)
Abstract References ORCID
94.15 17
36 FACTORS AFFECTING THE UTILIZATION OF SYSTEMATIC REVIEWS (10.1017/s0266462300105069)
References ORCID
93.17 72
37 A COMPARISON OF STANDARD GAMBLE, TIME TRADE-OFF, AND ADJUSTE… (10.1017/s0266462300161124)
References ORCID
91.63 67
38 COST-EFFECTIVENESS ANALYSIS: CAN WE REDUCE VARIABILITY IN CO… (10.1017/s0266462303000369)
References ORCID
91.63 67
39 THE USE OF CONJOINT ANALYSIS TO ELICIT WILLINGNESS-TO-PAY VA… (10.1017/s0266462300161227)
References ORCID
91.30 66
40 Effectiveness and efficiency of guideline dissemination and… (10.1017/s0266462305290190)
References ORCID
90.98 65
41 PATIENTS' PREFERENCES REGARDING THE PROCESS AND OUTCOMES OF… (10.1017/s0266462399015263)
References ORCID
90.65 64
42 HEALTH TECHNOLOGY DIFFUSION RATES (10.1017/s0266462300102053)
Abstract References ORCID
90.31 15
43 MOTIVATED PATIENTS ARE MORE COST-EFFECTIVELY REHABILITATED (10.1017/s0266462300102120)
Abstract References ORCID
90.31 15
44 A NOTE ON QALYS VERSUS HYES (10.1017/s0266462300103265)
Abstract References ORCID
90.31 15
45 IMPLEMENTING CLINICAL GUIDELINES IN THE TREATMENT OF DIABETE… (10.1017/s0266462300161185)
References ORCID
89.97 62
46 CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE,… (10.1017/s026646230200034x)
References ORCID
89.27 60
47 A ROLE FOR CONJOINT ANALYSIS IN TECHNOLOGY ASSESSMENT IN HEA… (10.1017/s0266462399315312)
References ORCID
89.27 60
48 FACTORS OF THE INNOVATION, ORGANIZATION, ENVIRONMENT, AND IN… (10.1017/s0266462301107026)
References ORCID
88.91 59
49 COMPARISON OF AN ORDINAL AND A CONTINUOUS OUTCOME MEASURE OF… (10.1017/s0266462399154102)
References ORCID
88.54 58
50 COST-BENEFIT ANALYSIS OF MAMMOGRAPHY SCREENING IN DENMARK BA… (10.1017/s0266462300102089)
Abstract References ORCID
88.21 14